Search

Author/Creator Jani, Meghna

1. "Take up to eight tablets per day": Incorporating free‐text medication instructions into a transparent and reproducible process for preparing drug exposure data for pharmacoepidemiology. Issue 6 (11th February 2023)

Authors:
Jani, Meghna; Yimer, Belay Birlie; Selby, David; Lunt, Mark; Nenadic, Goran; Dixon, William G.
Journal:
Pharmacoepidemiology and drug safety
Issue:
Volume 32:Issue 6(2023)
Page Start:
651
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. 2022 EULAR points to consider for remote care in rheumatic and musculoskeletal diseases. Issue 8 (25th April 2022)

Authors:
de Thurah, Annette; Bosch, Philipp; Marques, Andrea; Meissner, Yvette; Mukhtyar, Chetan B; Knitza, Johannes; Najm, Aurélie; Østerås, Nina; Pelle, Tim; Knudsen, Line Raunsbæk; Šmucrová, Hana; Berenbaum, Francis; Jani, Meghna; Geenen, Rinie; Krusche, Martin; Pchelnikova, Polina; de Souza, Savia; Ba...
Journal:
Annals of the rheumatic diseases
Issue:
Volume 81:Issue 8(2022)
Page Start:
1065
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Clinical utility of random anti-tumour necrosis factor drug testing and measurement of anti-drug antibodies on long-term treatment response in rheumatoid arthritis. (26th February 2015)

Authors:
Jani, Meghna; Chinoy, Hector; Warren, Richard B; Griffiths, Christopher E M; Plant, Darren; Morgan, Ann W; Wilson, Anthony G; Hyrich, Kimme L; Isaacs, John; Barton, Anne
Journal:
Lancet
Issue:
Volume 385(2015)Supplement 1
Page Start:
S48
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. Clinical Utility of Random Anti–Tumor Necrosis Factor Drug–Level Testing and Measurement of Antidrug Antibodies on the Long‐Term Treatment Response in Rheumatoid Arthritis. Issue 8 (28th July 2015)

Authors:
Jani, Meghna; Chinoy, Hector; Warren, Richard B.; Griffiths, Christopher E. M.; Plant, Darren; Fu, Bo; Morgan, Ann W.; Wilson, Anthony G.; Isaacs, John D.; Hyrich, KimmeL.; Barton, Anne; on behalf of the Biologics in Rheumatoid Arthritis Genetics and Genomics Study Syndicate Collaborators; Prouse...
Journal:
Arthritis & rheumatology
Issue:
Volume 67:Issue 8(2015)
Page Start:
2011
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. Drug-specific risk, and associated factors, of vasculitis-like events in patients exposed to tumour necrosis factor alpha inhibitor therapy: results from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis (BSRBR-RA). (25th February 2016)

Authors:
Jani, Meghna; Dixon, William G; Kearsley-Fleet, Lianne; Bruce, Ian N; Chinoy, Hector; Barton, Anne; Lunt, Mark; Watson, Kath; Symmons, Deborah P; Hyrich, Kimme
Journal:
Lancet
Issue:
Volume 387(2016)Supplement 1
Page Start:
S55
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗